Dexcom (DXCM) Total Liabilities (2010 - 2026)

Dexcom (DXCM) has reported Total Liabilities for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Liabilities fell 19.35% year-over-year to $3.8 billion in Q2 2026; TTM through Jun 2026 was $3.8 billion, a 19.35% decrease from a year earlier, with the FY2025 full-year figure at $3.6 billion, down 17.98% from the prior year.
• Total Liabilities was $3.8 billion for Q2 2026 at Dexcom, up from $3.7 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $4.8 billion in Q3 2025 and troughed at $2.9 billion in Q1 2022.
• A 5-year average of $4.0 billion and a median of $4.2 billion in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 59.39% in 2023 and declined 19.35% in 2026, its largest moves.
• Over 5 years, Total Liabilities stood at $3.3 billion in 2022, then climbed by 28.71% to $4.2 billion in 2023, then increased by 4.43% to $4.4 billion in 2024, then retreated by 17.98% to $3.6 billion in 2025, then increased by 6.68% to $3.8 billion in 2026.
• The last three Total Liabilities figures came in at $3.8 billion (Q2 2026), $3.7 billion (Q1 2026), and $3.6 billion (Q4 2025), per Business Quant data.